|
- 2015
维持性血液透析患者血清Hepcidin、sTfR测定在铁缺乏中的应用价值
|
Abstract:
摘要:目的 检测维持性血液透析患者(MHD)、非透析终末期肾脏疾病患者(ESRD)血清中铁调素(hepcidin)和血清转铁蛋白受体(serum transferring receptor, sTfR)的水平变化,探讨其在肾性贫血铁缺乏中的作用。方法 选择维持性血液透析患者80例、非透析终末期肾脏疾病患者80例,健康体检者80例作为对照组。ELISA法检测血清Hepcidin、sTfR、总铁结合力(TIBC),同时测定血清铁(Fe)、铁蛋白(FER)、血清转铁蛋白(TRF),比较组间差异。结果 ①维持性血液透析患者和非透析终末期肾脏疾病患者血清hepcidin和sTfR水平均明显升高,差异有统计学意义(P<0.01)。②与非透析ESRD组相比,MHD组的血清hepcidin和sTfR水平显著升高,差异有统计学意义(P<0.05)。③相关分析显示,血清hepcidin与Scr、hs-CRP、血清铁(Fe)、铁蛋白(FER)呈正相关,r分别为0.515、0.312、0.290、0.286,P均<0.01;与HGB、eGFR、HCT、TRF、TIBC呈负相关,r分别为-0.466、-0.362、-0.285、-0.248、-0.224,P<0.05。④血清sTfR水平与铁蛋白、转铁蛋白饱和度(TSAT)有相关性,相关系数分别为-0.764、-0.519,P均<0.01;与血红蛋白和红细胞压积有相关性,相关系数分别为0.378和0.514,P均<0.01。⑤血清hepcidin、sTfR联合铁蛋白或转铁蛋白饱和度诊断缺铁时,绘制受试者工作特征曲线(receiver operating characteristic curve, ROC),曲线下面积为90.8%,对应的灵敏度为93.3%,特异度为77%。 结论 血清hepcidin、 sTfR 联合铁蛋白或转铁蛋白饱和度对于ESRD患者合并肾性贫血铁缺乏的评估及治疗有重要意义。
ABSTRACT: Objective To detect the changes of serum hepcidin and serum transferrin receptor (sTfR) levels in patients on maintenance hemodialysis (MHD) and those end-stage renal disease (ESRD) patients not on dialysis so as to explore their role in renal iron-deficiency anemia. Methods A total of 80 patients on MHD, 80 ESRD patients not on dialysis, and 80 healthy controls were enrolled in this study. Serum hepcidin, sTfR and total iron-binding capacity (TIBC) were measured by ELISA. Serum Fe, ferritin (FER) and transferrin (TRF) were measured by routine methods. Data were compared among the groups. Results ① Serum hepcidin and sTfR levels were significantly higher in patients on MHD and ESRD patients not on dialysis than in the healthy controls (P<0.01). ② Serum hepcidin and sTfR were significantly higher in patients on MHD than in ESRD patients not on dialysis (P<0.05). ③ Pearson correlation analysis revealed that serum hepcidin was positively correlated with Scr (r=0.515), hs-CRP (r=0.312), serum Fe (r=0.290) and FER (r=0.286) (all P<0.01); but negatively correlated with HGB (r= -0.466), eGFR (r=-0.362), HCT(r=-0.285), TRF(r=-0.248) and TIBC (r=-0.224) (P<0.05). ④ Pearson correlation analysis revealed that sTfR was positively correlated with HGB (r=0.378) and HCT (r=0.514) (both P<0.01), but negatively correlated with FER (r= -0.764) and TSAT(r=-0.519) (both P<0.01). ⑤ The area of serum hepcidin, sTfR and FER or TSAT under the ROC curve was 90.8%, and the sensitivity and specificity were 93.3% and 77%, respectively. Conclusion Serum hepcidin, sTfR and ferritin or transferrin saturation is important for assessing and treating ESRD patients with renal iron-deficiency anemia
[1] | 李诗琪,彭奕冰. 可溶性转铁蛋白受体/铁指数对慢性肾衰竭伴缺铁性贫血的诊断价值分析[J]. 国际检验医学杂志, 2012, 33(19):2420-2421. |
[2] | KURAGANO T, ITOH K, SHIMONAKA Y, et al. Hepcidin as well as TNF-α are significant predictors of arterial stiffness in patients on maintenance hemodialysis[J]. Nephrol Dial Transplant, 2011, 26(8):2663-2667. |
[3] | RICHARD J, CHIA CT, GLORIA C, et al. Understanding the structure/activity relationships of the iron regulatory peptide hepcidin[J]. Chem & Biol, 2011, 18(3):336-343. |
[4] | HURTADO-TORRES GF, CASTANEDO-CAZARES JP. Soluble receptor of trans- ferrin (sTfR) as a marker of iron deficiency in inflammatory conditions[J]. Nutr Clin Pract, 2013, 28(4):522-523. |
[5] | SANDVIK K. Iron levels and plasma sTfR[J]. Tidsskr Nor Laegeforen, 2013, 133(6):609-610. |
[6] | 杨阳,张艳,罗浪,等. 铁代谢异常与人体疾病研究进展[J]. 吉林医学, 2011, 32(2):328-321. |
[7] | 张妍,周晓玲,陈孟华. 终末期肾脏病患者血清中铁调素的水平变化及其铁代谢的关系[J]. 中国血液净化,2011, 10(7):371-375. |
[8] | CAMASCHELLA C. Iron and hepcidin: a story of recycling and balance[J]. Hematology Am Soc Hematol Educ Program, 2013, 1(1):1-8.. |
[9] | 杨敏,何小周,周萃星,等. 腹膜透析患者铁调素表达变化及与肾性贫血、微炎性反应的相关性分析[J]. 中华肾脏病杂志, 2013, 29(8):595-599. |
[10] | FUNG E, NEMETH E. Manipulation of the hepcidin pathway for therapeutic purposes[J]. Bibl Haematol, 2013, 98(11):1667-1676. |
[11] | 李寒,王世相. 维持性血液透析患者铁代谢状况的初步分析[J]. 中国血液净化,2010,9(9):482-485. |
[12] | 美国NKF-K/DOQI工作组.慢性肾脏及透析的临床实践指南Ⅱ[M]. 北京:人民卫生出版社,2003:13-15. |
[13] | KEW MC. Hepatic iron overload and hepatocellular carcinoma[J]. Liver Cancer, 2014, 3(1):31-40. |
[14] | 徐颜,邹建洲,刘中华,等. 血清铁调素与血液透析患者铁负荷及微炎症状态相关[J]. 上海医学,2012, 35(3):242-246. |
[15] | RAFI A, KARKAR A, ABODELRAHMAN M. Monitoring iron status in end-stage renal disease patients on hemdialysis[J]. Saudi J Kidney Dis Transpl, 2007, 18(1):73-78. |
[16] | 袁群生,郑法雷,刘鹏举. 铁调素对慢性肾脏病患者铁代谢的调节作用及其机制[J]. 中国血液净化, 2010, 9(9):473-476. |